Nimbus Therapeutics announced the launch of a first-in-human clinical trial for NDI-219216, its investigational Werner ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough ...

Early clinical and preclinical findings presented at the 35th European Society of Clinical Microbiology and Infectious ...

Purdue University scientists have identified the Supinoxin molecule as a possible new therapy for small cell lung cancer.